Myriad Genetics buy The Goldman Sachs Group, Inc.
Start price
07.05.25
/
50%
€4.00
Target price
07.05.26
€7.05
Performance (%)
-14.30%
End price
08.05.26
€3.43
Summary
This prediction ended on 08.05.26 with a price of €3.43. The prediction for Myriad Genetics disappointed with a performance of -14.30%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | -2.622% | -2.622% | 36.330% |
| iShares Core DAX® | 0,07 % | 0,24 % | 2,89 % |
| iShares Nasdaq 100 | -1,34 % | -3,37 % | 29,21 % |
| iShares Nikkei 225® | -2,31 % | -7,50 % | 56,32 % |
| iShares S&P 500 | -0,34 % | 0,90 % | 23,17 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $14.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten